¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
7/31 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2019-07-30
Á¶È¸¼ö
314


¾È³çÇϼ¼¿ä ±èÀ±¾ÆÀÔ´Ï´Ù.


Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº 2017³â 6¿ù¿¡ Nature Scientific Reports¿¡ ½Ç¸° ³í¹®À¸·Î
"Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic 
Escherichia coli K1 infection by accelerating development of intestinal defense" ÀÔ´Ï´Ù.
Lactobacillus rhamnosus GG supernatant°¡ neonatal Àå³» ȯ°æ¿¡¼­ E. coli K1 infectionÀ» ¸·´Â´Ù°í
¹àÈù ³í¹®ÀÔ´Ï´Ù. ±âÁ¸ live LGG°¡ ¾Æ´Ñ supernatant¸¸À¸·Î °°Àº È¿°ú°¡ ÀÖÀ½À»
º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù.

ºÎÁ·ÇÏÁö¸¸ ¿­½ÉÈ÷ ÁغñÇÏ¿© ¼ö¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù 


±èÀ±¾Æ ¿Ã¸²



¹ßÇ¥³í¹® ¸µÅ©: https://www.nature.com/articles/srep43305#results
 Ã·ºÎÆÄÀÏ:
Lactobacillus rhamnosus GG supernatant.pdf (2.14MB)
´ÙÀ½±Û
8/3 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ ÁÖ¿µÁØ
¾È³çÇϼ¼¿ä ¿µÁØÀÔ´Ï´Ù.Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº ÀÛ³â 7¿ùNature¿¡ ½Ç¸° ³í¹®À¸·Î P2RX7ÀÌ memory CD8 T cellÀÇ ºÐÈ­¿¡ Áß¿äÇÏ´Ù´Â °ÍÀ» º¸¿©ÁØ ³í¹®ÀÔ´Ï´Ù.Á¦°¡ ¼öÇàÇÏ´Â ¿¬±¸¿Í °°Àº pathogen (LCMV) À» »ç¿ëÇß°í, KLRG1, CD127 À» ÀÌ¿ëÇÑ precursor ¿¡ °ü·ÃµÈ ºÎºÐµµ ´Ù·ç°í À־ ¼±Á¤ÇÏ¿´½À´Ï´Ù.¿­½ÉÈ÷ ÁغñÇÏ..
ÀÌÀü±Û
7/27 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù.
/ ±¸¹ÎÁ¤
¾È³çÇϼ¼¿ä,À̹ø ÁÖ ¹ßÇ¥¸¦ ¸ÃÀº ±¸¹ÎÁ¤ÀÔ´Ï´Ù.Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2015³â Nat Communications¿¡ ¹ßÇ¥µÈ °ÍÀ¸·Î"IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vg6+ gdT cells" ÀÔ´Ï´Ù.IL-17À» »ý¼ºÇÏ´Â gdT cell°ú IL-1r °£ÀÇ °ü°è¸¦ ÀÌÇØÇÏ..